MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 247 filers reported holding MIRATI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $898 | +24.2% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $723 | -0.4% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $726 | -14.1% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $845 | -100.0% | 20,000 | -46.1% | 0.00% | -75.0% |
| Q3 2022 | $2,564,000 | +4.0% | 37,140 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $2,465,000 | -24.9% | 37,140 | -4.5% | 0.01% | -12.5% |
| Q1 2022 | $3,284,000 | -42.1% | 38,890 | -1.5% | 0.01% | -42.9% |
| Q4 2021 | $5,676,000 | -4.4% | 39,490 | +15.5% | 0.01% | -17.6% |
| Q3 2021 | $5,936,000 | +8.3% | 34,190 | 0.0% | 0.02% | +6.2% |
| Q2 2021 | $5,480,000 | -2.9% | 34,190 | 0.0% | 0.02% | -15.8% |
| Q1 2021 | $5,643,000 | +13.8% | 34,190 | +51.4% | 0.02% | 0.0% |
| Q4 2020 | $4,960,000 | +9.1% | 22,590 | -18.0% | 0.02% | -5.0% |
| Q3 2020 | $4,545,000 | +196.5% | 27,550 | +105.6% | 0.02% | +100.0% |
| Q2 2020 | $1,533,000 | +112.3% | 13,400 | +52.7% | 0.01% | +66.7% |
| Q1 2020 | $722,000 | – | 8,775 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
| Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
| Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
| Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
| Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
| Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
| Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
| Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
| Trexquant Investment LP | 42,879 | $223,000 | 0.03% |